|
|
|
Volumn 32, Issue 1, 2005, Pages 28-32
|
|
Second-line chemotherapy for recurrent ovarian cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CAMPTOTHECIN;
CARBOPLATIN;
CISCA PROTOCOL;
CISPLATIN;
CYCLOPHOSPHAMIDE;
DOCETAXEL;
DOXORUBICIN;
DRUG DERIVATIVE;
ETOPOSIDE;
IRINOTECAN;
PACLITAXEL;
PLATINUM;
TAXOID;
DRUG ADMINISTRATION;
DRUG RESISTANCE;
FEMALE;
HUMAN;
OVARY TUMOR;
PATHOLOGY;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
REVIEW;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAMPTOTHECIN;
CARBOPLATIN;
CISPLATIN;
CLINICAL TRIALS, PHASE II;
CLINICAL TRIALS, PHASE III;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
DRUG ADMINISTRATION SCHEDULE;
DRUG RESISTANCE, NEOPLASM;
ETOPOSIDE;
FEMALE;
HUMANS;
OVARIAN NEOPLASMS;
PACLITAXEL;
PLATINUM;
TAXOIDS;
|
|
EID: 13744253119
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (11)
|
